Home/Filings/4/0001232524-08-000026
4//SEC Filing

JAZZ PHARMACEUTICALS INC 4

Accession 0001232524-08-000026

$JAZZCIK 0001232524operating

Filed

Jun 1, 8:00 PM ET

Accepted

Jun 2, 5:08 PM ET

Size

5.0 KB

Accession

0001232524-08-000026

Insider Transaction Report

Form 4
Period: 2008-05-30
Wissel Janne LT
SVP, Chief Regulatory Officer
Transactions
  • Other

    Common Stock

    2008-05-30$6.50/sh+1,278$8,307104,000 total
Footnotes (1)
  • [F1]Shares acquired through a qualified Section 423 Employee Stock Purchase Plan.

Issuer

JAZZ PHARMACEUTICALS INC

CIK 0001232524

Entity typeoperating
IncorporatedIreland

Related Parties

1
  • filerCIK 0001232524

Filing Metadata

Form type
4
Filed
Jun 1, 8:00 PM ET
Accepted
Jun 2, 5:08 PM ET
Size
5.0 KB